[#item_full_content] Yesterday, the Trump Administration issued an Executive Order titled “Increasing Medical Marijuana and Cannabidiol Research” (the “EO”). It directs the Attorney General to expedite the rulemaking process related to rescheduling marijuana to Schedule III of the Controlled Substances Act, representing a significant step forward in recognizing the medical benefit of cannabis. Read More
